Entera Bio Ltd. (ENTX) vs LifeMD, Inc. (LFMD)

A side-by-side comparison of Entera Bio Ltd. and LifeMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ENTX vs LFMD

growth of $100 · dividends reinvested · last 8y
ENTX -58.3% (-10.4%/yr)LFMD +136.5% (+11.4%/yr)LFMD compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $1002020202220242026$42$237
ENTX LFMD

ENTX vs LFMD: by the numbers

  • •LFMD is the larger company ($135M vs $128M market cap).
  • •Both run net losses; LFMD's is the smaller (-10.40% vs -27235.71% net margin).

Metrics side by side

Valuation

MetricENTXLFMD
P/S ratioN/A0.66
P/B ratio17.6716.91

Profitability

MetricENTXLFMD
Gross margin0.00%85.91%
Operating margin-27450.00%-9.35%
Net margin-27235.71%-10.40%
ROE-234.42%-266.86%
ROIC-82.87%-143.97%

Growth (annualized)

MetricENTXLFMD
Revenue CAGR (5Y)N/A26.00%
Total return CAGR (5Y)-10.57%-14.66%

Frequently asked

How have ENTX and LFMD total returns compared?
Over the past 5 years, ENTX delivered -10.57% and LFMD delivered -14.66% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.